CSL BEHRING LLC

H.R.7024, Tax Relief for American Families and Workers Act of 2024, as it relates to the R&D tax credit. Monitored H.R. 3665, Defending American Jobs & Investment Act, as it relates to taxation of foreign-based multinationals. Issues related to corporate international taxes, and the Orphan Drug Tax Credit. Issues related to the 2025 expiration of the Tax Cut and Jobs Act provisions impacting corporations.

Issues related to plasma therapies. H.R. 6465, Preserving Life-saving Access to Specialty Medicines in America Act. Issues related to gene therapies. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act and issues related to value-based payments. Issues related to drug shortages. Issues related to the Medicaid Drug Rebate Program. Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to plasma derived products and drug pricing. Monitored issues related to pharmacy benefit management.

Monitored issues related to medical supply chain and pharmacy benefit management. Monitored issues related to drug pricing.

H.R.7024, Tax Relief for American Families and Workers Act of 2024, as it relates to the R&D tax credit. Monitored H.R. 3665, Defending American Jobs & Investment Act, as it relates to taxation of foreign-based multinationals.

Issues related to gene therapy. Issues related to plasma therapies. H.R. 2666, the Medicaid VBPs for Patients (MVP) Act and issues related to value-based payment arrangements. Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to plasma derived products and drug pricing. Monitored issues related to pharmacy benefit management. Issues related to drug shortages. Issues related to the Medicaid Drug Rebate Program. H.R.6465, PLASMA Act - Preserving Life-saving Access to Specialty Medicines in America Act.